Search

Your search keyword '"Hill, Adrian V. S."' showing total 1,392 results

Search Constraints

Start Over You searched for: Author "Hill, Adrian V. S." Remove constraint Author: "Hill, Adrian V. S."
1,392 results on '"Hill, Adrian V. S."'

Search Results

1. The Genomic Landscape of Oceania

2. High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response

3. Ancestry-specific analyses of genome-wide data confirm the settlement sequence of Polynesia

4. Mexican Biobank advances population and medical genomics of diverse ancestries

5. The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study

6. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

7. Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial

8. Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial

11. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

12. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

13. Paths and timings of the peopling of Polynesia inferred from genomic networks

14. Malaria is a cause of iron deficiency in African children

16. Native American gene flow into Polynesia predating Easter Island settlement

27. Estimating the burden of iron deficiency among African children

29. Language continuity despite population replacement in Remote Oceania

31. Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01 B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP

32. Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01

34. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

35. High-resolution African HLA resource uncovers HLA-DRB1expression effects underlying vaccine response

39. A tool for evaluating heterogeneity in avidity of polyclonal antibodies

40. A Phase 1b Clinical Trial to Determine the Safety, Tolerability and Immunogenicity of the Candidate Mycobacterium Avium Complex Subspecies Vaccines ChAdOx2 HAV and MVA HAV in Patients with Active Crohn's Disease

41. A Phase III Randomised Controlled Trial Evaluating the Malaria Vaccine Candidate R21/Matrix-M™ in African Children

42. The Public Health Impact and Cost-Effectiveness of the R21/Matrix-M Malaria Vaccine: A Mathematical Modelling Study

45. Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals

46. Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso

47. Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus

Catalog

Books, media, physical & digital resources